{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:20Z","timestamp":1793946620397,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["118C263"],"award-info":[{"award-number":["118C263"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020410","name":"T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131","doi-asserted-by":"publisher","award":["35722"],"award-info":[{"award-number":["35722"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020410","name":"T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131","doi-asserted-by":"publisher","award":["34150"],"award-info":[{"award-number":["34150"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114910","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:43:40Z","timestamp":1775493820000},"page":"114910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microfluidics-assisted Aprotinin-based nano-carrier for Valproic acid delivery"],"prefix":"10.1016","volume":"394","author":[{"given":"Faiqa","family":"Nazir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Yesiloz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2026.114910_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114910_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108108","article-title":"Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response","volume":"236","author":"Yu","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114910_bb0015","doi-asserted-by":"crossref","DOI":"10.4137\/BCBCR.S29420","article-title":"Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies","author":"Nounou","year":"2015","journal-title":"Breast Cancer Basic Clin. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114910_bb0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.52601\/bpr.2021.210042","article-title":"Health science center, school of pharmacy, xian jiaotong university, xian 710061, China. A review for cell-based screening methods in drug discovery","volume":"7","author":"Fen","year":"2021","journal-title":"Biophys. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114910_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158116","article-title":"Influence of matrices on 3D-cultured prostate cancer cells drug response and expression of drug-action associated proteins","volume":"11","author":"Edmondson","year":"2016","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.jconrel.2026.114910_bb0035","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.3390\/ijms20194926","article-title":"Scaffold-free 3-D cell sheet technique bridges the gap between 2-D cell culture and animal models","volume":"20","author":"Alghuwainem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114910_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/2472555219830087","article-title":"3D cell-based assays for drug screens: challenges in imaging, image analysis, and high-content analysis","volume":"24","author":"Booij","year":"2019","journal-title":"SLAS Discov."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114910_bb0045","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-3338","article-title":"Landscape of combination immunotherapy and targeted therapy to improve cancer management","volume":"77","author":"Colli","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"02","key":"10.1016\/j.jconrel.2026.114910_bb0055","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000164","article-title":"Paclitaxel nano-delivery systems: a comprehensive review","volume":"04","author":"Ma","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114910_bb0060","doi-asserted-by":"crossref","first-page":"18311","DOI":"10.1021\/acsami.3c16548","article-title":"A microfluidics-assisted double-barreled nanobioconjugate synthesis introducing aprotinin as a new moonlight nanocarrier protein: tested toward physiologically relevant 3D-spheroid models","volume":"16","author":"Nazir","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114910_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.17219\/acem\/89770","article-title":"Anti-neoplastic effects of aprotinin on humanbreast cancer cell lines: in vitro study","volume":"28","author":"Soleyman-Jahi","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"issue":"03","key":"10.1016\/j.jconrel.2026.114910_bb0070","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1055\/s-0041-1735154","article-title":"Aprotinin inhibits thrombin generation by inhibition of the intrinsic pathway, but is not a direct thrombin inhibitor","volume":"05","author":"Lisman","year":"2021","journal-title":"TH Open"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114910_bb0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1067\/mtc.2000.106323","article-title":"An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation","volume":"120","author":"Asimakopoulos","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114910_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/bja\/aeh227","article-title":"Perioperative systemic haemostatic agents","volume":"93","author":"Mahdy","year":"2004","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114910_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jnutbio.2013.10.002","article-title":"Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals","volume":"25","author":"Wang","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114910_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/1061186X.2015.1015537","article-title":"Aprotinin revisited: formulation, characterization, biodistribution and therapeutic potential of new aprotinin microemulsion in acute pancreatitis","volume":"23","author":"Karasulu","year":"2015","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114910_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/pharmaceutics12070604","article-title":"Protein-based nanoparticles as drug delivery systems","volume":"12","author":"Hong","year":"2020","journal-title":"Pharmaceutics"},{"issue":"01","key":"10.1016\/j.jconrel.2026.114910_bb0100","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6798.1000118","article-title":"Anti-convulsant drug valproic acid in cancers and in combination anti-cancer therapeutics","volume":"02","author":"David H Coy","year":"2014","journal-title":"Mod. Chem. Appl."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13578-019-0312-0","article-title":"Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3\/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells","volume":"9","author":"Li","year":"2019","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-023-04015-8","article-title":"Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner","volume":"21","author":"Giordano","year":"2023","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114910_bb0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114910_bb0120","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/pharmaceutics14081566","article-title":"Nanocarriers: a reliable tool for the delivery of anticancer drugs","volume":"14","author":"Sabit","year":"2022","journal-title":"Pharmaceutics"},{"issue":"51","key":"10.1016\/j.jconrel.2026.114910_bb0125","doi-asserted-by":"crossref","first-page":"70187","DOI":"10.1021\/acsami.4c12524","article-title":"Unlocking natures potential: ferritin as a universal nanocarrier for amplified cancer therapy testing via 3D microtissues","volume":"16","author":"Munir","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114910_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104404","article-title":"Pharmacokinetics and tumor delivery of nanoparticles","volume":"83","author":"Yuan","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114910_bb0135","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/acs.analchem.0c04431","article-title":"Microwave heating induced on-demand droplet generation in microfluidic systems","volume":"93","author":"Cui","year":"2021","journal-title":"Anal. Chem."},{"issue":"20","key":"10.1016\/j.jconrel.2026.114910_bb0140","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1039\/C5LC00314H","article-title":"Label-free high-throughput detection and content sensing of individual droplets in microfluidic systems","volume":"15","author":"Yesiloz","year":"2015","journal-title":"Lab Chip"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114910_bb0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13346-012-0064-4","article-title":"Drug release from nanomedicines: selection of appropriate encapsulation and release methodology","volume":"2","author":"Wallace","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"issue":"56","key":"10.1016\/j.jconrel.2026.114910_bb0150","doi-asserted-by":"crossref","first-page":"44998","DOI":"10.1039\/C5RA05803A","article-title":"Fabrication of a pH responsive DOX conjugated PEGylated palladium nanoparticle mediated drug delivery system: an in vitro and in vivo evaluation","volume":"5","author":"Shanthi","year":"2015","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114910_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2710.2007.00831.x","article-title":"Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy","volume":"32","author":"Dutta","year":"2007","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nprot.2006.28","article-title":"Isothermal titration calorimetry to determine association constants for high-affinity ligands","volume":"1","author":"Velazquez-Campoy","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.114910_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.100880","article-title":"Molecular modeling in drug discovery","volume":"29","author":"Adelusi","year":"2022","journal-title":"Inform. Med. Unlocked"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114910_bb0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00894-023-05531-6","article-title":"Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations","volume":"29","author":"Ashiru","year":"2023","journal-title":"J. Mol. Model."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/364819","article-title":"Ligand-based and structure-based investigation for alzheimers disease from traditional chinese medicine","volume":"2014","author":"Liao","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2045-8118-11-26","article-title":"Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence","volume":"11","author":"Hladky","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2026.114910_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114910_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0168-9525(03)00167-7","article-title":"Moonlighting proteins: old proteins learning new tricks","volume":"19","author":"Jeffery","year":"2003","journal-title":"Trends Genet."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114910_bb0195","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.bbamcr.2017.05.013","article-title":"New intracellular activities of matrix metalloproteinases shine in the moonlight","volume":"1864","author":"Jobin","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114910_bb0200","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1021\/es900249m","article-title":"Characterizing manufactured nanoparticles in the environment: multimethod determination of particle sizes","volume":"43","author":"Domingos","year":"2009","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114910_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbiotec.2018.10.003","article-title":"Monitoring of antibody-drug conjugation reactions with UV\/Vis spectroscopy","volume":"288","author":"Andris","year":"2018","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114910_bb0210","series-title":"Profiles of Drug Substances, Excipients and Related Methodology","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0099-5428(05)32008-9","article-title":"Valproic acid and sodium valproate: Comprehensive profile","volume":"32","author":"Alsarra","year":"2005"},{"key":"10.1016\/j.jconrel.2026.114910_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120355","article-title":"Lactoferrin, a multi-functional glycoprotein: active therapeutic, drug nanocarrier & targeting ligand","volume":"263","author":"Elzoghby","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dta.3362","article-title":"Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC\u2013MS\/MS) in whole blood for forensic purposes","volume":"15","author":"Pascali","year":"2023","journal-title":"Drug Test Anal."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114910_bb0225","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1021\/acs.analchem.5b01451","article-title":"Method to determine protein concentration in the protein\u2013nanoparticle conjugates aqueous solution using circular dichroism spectroscopy","volume":"87","author":"Li","year":"2015","journal-title":"Anal. Chem."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114910_bb0230","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1074\/jbc.RA118.007292","article-title":"Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin","volume":"294","author":"Cohen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114910_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.04.048","article-title":"Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials","volume":"135","author":"Briquez","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114910_bb0240","series-title":"Biochemistry and Applications of Aprotinin, the Kallikrein Inhibitor from Bovine Organs","author":"Fritz","year":"2026"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114910_bb0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114910_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbagen.2008.09.004","article-title":"Ferritins: a family of molecules for iron storage, antioxidation and more","volume":"1790","author":"Arosio","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2026.114910_bb0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114910_bb0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114910_bb0265","first-page":"314","article-title":"PH-sensitive polymeric micelles for the effective delivery of anti-cancer drug","volume":"49","author":"Na","year":"2007","journal-title":"Korean J. Gastroenterol. Taehan Sohwagi Hakhoe Chi"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114910_bb0270","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114910_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2009.06.028","article-title":"CPP\u2013protein constructs induce a population of non-acidic vesicles during trafficking through Endo-lysosomal pathway","volume":"139","author":"R\u00e4\u00e4gel","year":"2009","journal-title":"J. Control. Release"},{"issue":"14","key":"10.1016\/j.jconrel.2026.114910_bb0280","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3390\/cancers13143409","article-title":"Valproic acid and breast cancer: state of the art in 2021","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114910_bb0285","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211027524","article-title":"Valproic acid suppresses breast cancer cell growth through triggering pyruvate kinase m2 isoform mediated Warburg effect","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transplant."},{"key":"10.1016\/j.jconrel.2026.114910_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","article-title":"Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer","volume":"835","author":"Heers","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114910_bb0295","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1007\/s11033-023-08568-1","article-title":"The evidence for repurposing anti-epileptic drugs to target cancer","volume":"50","author":"Aroosa","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114910_bb0300","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1158\/0008-5472.CAN-05-3077","article-title":"The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells","volume":"66","author":"Grantab","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114910_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062630","article-title":"Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and taxotere\u00ae","volume":"8","author":"Mikhail","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0310","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1038\/s41598-019-43090-0","article-title":"Characterization of the physical properties of tumor-derived spheroids reveals critical insights for pre-clinical studies","volume":"9","author":"Guillaume","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114910_bb0315","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/toxics11050471","article-title":"Mitochondrial toxic effects of antiepileptic drug valproic acid on mouse kidney stem cells","volume":"11","author":"Lee","year":"2023","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/1735-5362.220963","article-title":"Mitochondrial and caspase pathways are involved in the induction of apoptosis by nardosinen in MCF-7 breast cancer cell line","volume":"13","author":"Shahali","year":"2018","journal-title":"Res. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114910_bb0325","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40262-024-01418-8","article-title":"Physiologically-based pharmacokinetic modeling of total and unbound valproic acid to evaluate dosing in children with and without hypoalbuminemia","volume":"63","author":"Karatza","year":"2024","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114910_bb0330","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1523-1755.2002.00501.x","article-title":"The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology","volume":"62","author":"Verroust","year":"2002","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0335","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41401-021-00628-1","article-title":"Renal effects of the serine protease inhibitor aprotinin in healthy conscious mice","volume":"43","author":"W\u00f6rner","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114910_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103967","article-title":"Valproic acid induced liver injury: an insight into molecular toxicological mechanism","volume":"95","author":"Ezhilarasan","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114910_bb0345","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/20009666.2018.1514933","article-title":"Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review","volume":"8","author":"Gayam","year":"2018","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.jconrel.2026.114910_bb0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted role of the Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications","volume":"8","author":"Mahmood","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114910_bb0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114910_bb0360","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00424-023-02841-9","article-title":"Measured GFR in murine animal models: review on methods, techniques, and procedures","volume":"475","author":"Teixido-Trujillo","year":"2023","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.jconrel.2026.114910_bb0365","series-title":"Methods for Hemolysis Interference Study in Laboratory Medicine \u2013 a Critical Review","author":"Marques-Garcia","year":"2026"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:04:34Z","timestamp":1793945074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S0168365926003123"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114910","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microfluidics-assisted Aprotinin-based nano-carrier for Valproic acid delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114910"}}